SCHEMBL7417008

SCHEMBL7417008

O=C(NO)C(CNS(=O)(=O)c1ccc(F)cc1F)NS(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 4/20 0.55
ADAM17 P78536 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SLC6A9 P48067 5/20 0.42
MMP10 P09238 1/20 0.42
MMP9 P14780 1/20 0.42
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
BMP1 P13497 1/20 0.40
SCN1A P35498 2/20 0.40
SCN2A Q99250 2/20 0.40
SCN3A Q9NY46 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418545 1.00 MMP7 (0.55) MMP7ADAM17HTTSMN1; SMN2SLC6A9
SCHEMBL7418330 0.88 MMP7 (0.58) MMP7ADAM17MMP10MMP9BMP1
SCHEMBL7410576 0.88 MMP7 (0.65) MMP7ADAM17SLC6A9MMP10MMP9
SCHEMBL7419234 0.80 MMP7 (0.53) MMP7ADAM17HTTSLC6A9SLC1A3
SCHEMBL7417272 0.80 MMP7 (0.53) MMP7ADAM17HTTSLC6A9SLC1A3
SCHEMBL7416827 0.79 MMP7 (0.51) MMP7ADAM17SLC6A9MMP10MMP9
SCHEMBL7412021 0.79 MMP7 (0.48) MMP7ADAM17MMP10MMP9BMP1
SCHEMBL7414873 0.79 MMP7 (0.48) MMP7ADAM17MMP10MMP9BMP1
SCHEMBL7411514 0.79 MMP7 (0.51) MMP7ADAM17SLC6A9MMP10MMP9
SCHEMBL7410769 0.78 NPY5R (0.61) MMP7ADAM17SLC6A9MMP10MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed